Synthes
-
Recon
DePuy Synthes announced that it has acquired Olive Medical Corporation
Visualization Platform Technology and Expertise to Broaden Arthroscopy Portfolio Raynham, Mass. (February 10, 2015) –Today DePuy Synthes Companies announced that…
Read More » -
Spine
DePuy Synthes Spine wins expanded approval for Synapse spinal device
February 2, 2015 by Val Kennedy Johnson & Johnson’s DePuy Synthes Spine unit wins expanded FDA clearance for its Synapse…
Read More » -
Biologics
DePuy Synthes Companies Introduces ViviGen™ Cellular Bone Matrix, New Cellular Allograft For Spinal Fusion
SAN FRANCISCO, Nov. 12, 2014 /PRNewswire/ — DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health®, today…
Read More » -
Extremities
Wright Medical-Tornier merger — Can they compete with Zimmer & DePuy Synthes in extremities?
Written by Laura Dyrda The Wright Medical Group merger with Tornier has the orthopedic device industry buzzing, heralded as a…
Read More » -
Extremities
JNJ continues to pay hefty integration charges on Synthes deal
October 16, 2014 by Brian Johnson More than 2½ years after it spent $21.3 billion on Synthes, Johnson & Johnson…
Read More » -
Extremities
DePuy Synthes releases new variable angle plating systems for calcaneal fractures, fusion procedures
New VA LCP® Plating Systems are Designed to Advance Patient Care By Offering Comprehensive Treatment Options Today DePuy Synthes Companies…
Read More » -
Uncategorized
DEPUY SYNTHES CONTINUES COST-CUTTING
Walter Eisner • Mon, July 28th, 2014 DePuy Synthes continues its cost-cutting measures. According to a July 17, 2014, Wall Street…
Read More » -
Uncategorized
Judge: Ex-Synthes sales manager broke noncompete
June 13, 2014 by Brad Perriello A federal judge rules that former Synthes sales rep John Marotta broke a non-compete agreement when…
Read More » -
Financial
J&J’s Med Tech Buisness Falters Amid Weak Sales,
The calendar has finally caught up with Johnson & Johnson ($JNJ). Quarter after quarter, the healthcare giant watched its $21.3…
Read More » -
Spine
Globus Medical Announces Jury Verdict in Patent Infringement Lawsuit
AUDUBON, Pa.–(BUSINESS WIRE)– Globus Medical, Inc. (GMED), a leading spinal implant manufacturer, today announced that the jury in a patent infringement case…
Read More » -
Uncategorized
J&J/Synthes Merger Less than Half Complete
Johnson & Johnson (New Brunswick, NJ) faces some setbacks with its $21.3 billion acqusition of Synthes. According toFinanz und Wirtschaft, a…
Read More » -
Spine
Spinal Kinetics Wins Another Round in Synthes’ Patent Litigation
SUNNYVALE, CA–(Marketwire – May 15, 2012) – Spinal Kinetics, Inc., the designer and manufacturer of the innovative M6® Artificial Disc,…
Read More » -
Extremities
J&J Wins EU Approval for $21.3 Billion Synthes Acquisition
Johnson & Johnson (JNJ) won European Union approval for its $21.3 billion purchase ofSynthes Inc. (SYST) after agreeing to sell its DePuy…
Read More » -
Extremities
Former Synthes sales rep counter-sues in generic ortho devices battle
April 6, 2012 by MassDevice staff Former Synthes sales rep turned Emerge Medical CEO John Marotta filed a countersuit against the med-tech…
Read More » -
Biologics
Kuros, Synthes to Co-Develop Bioactive Materials for Specified Applications
Swiss biomaterials firm Kuros Biosurgery and Synthes inked a license and development agreement under which they will work together commercialize Kuros’ synthetic matrix technology in specified…
Read More »